Martina Barash

Alexandria

Reporter at Bloomberg Law

Reporter covering product liability and other issues @blaw. Knitter. Tweets my own. RTs not endorsements.

Articles

Avis Budget Group Leaders Sued Over Rotation Strategy, Losses

3 weeks ago | news.bloomberglaw.com | Martina Barash

COURT: D.N.J.TRACK DOCKET: No. 2:25-cv-07934 (Bloomberg Law subscription)Avis Budget Group directors and top executives failed to disclose the company was speeding up the rotation of its rental car fleets, causing a dramatic financial impact, an investor alleges. The shift, which followed a Covid-19 pandemic slowdown in vehicle rotation, resulted in about $2.5 billion in impairment and other charges, Andrew Jones says on behalf of the company.
DermTech Investors Advance Suit Over Cancer Test Device Revenue

3 weeks ago | news.bloomberglaw.com | Martina Barash

DermTech Inc. investors adequately alleged that the skin cancer test maker’s statements about sales and revenue amounted to securities fraud, a federal court ruled after throwing out an earlier version of the complaint. The investors can proceed with claims over three categories of statements, Judge Dana M. Sabraw said Thursday for the US District Court for the Southern District of California.
Conflicts Tainted KnowBe4 Take-Private Merger, Investor Says

3 weeks ago | news.bloomberglaw.com | Martina Barash

COURT: S.D. Fla. TRACK DOCKET: No. 1:25-cv-22574 (Bloomberg Law subscription)Most KnowBe4 Inc. investors received less value than they should have from the online security company’s 2023 take-private merger into Vista Equity Partners Management LLC, according to a proposed class action.
Ripple Locked in Standoff With Judge Blocking SEC Crypto Accord

3 weeks ago | news.bloomberglaw.com | Martina Barash

Deep DiveJune 4, 2025, 9:00 AM UTC US President Donald Trump shakes hands with Securities and Exchange Commission Chairman Paul Atkins during Atkins' swearing-in ceremony in the Oval Office at the White House on April 22. Having previously served as a commissioner at the SEC under President George W. Bush, Atkins is free-market, pro-business conservative and is expected to take a lighter regulatory touch on crypto and other digital assets.
Lovesac Leaders Get First Nod for Internal Reform Settlement

3 weeks ago | news.bloomberglaw.com | Martina Barash

A settlement agreement by Lovesac Co. directors and officers to implement at least 10 categories of internal corporate reforms over accounting allegations warrants preliminary approval, a federal court said Tuesday. Judge Victor A. Bolden gave the derivative suit settlement the go-ahead just a day after investors submitted the terms of the deal and their approval request to the US District Court for the District of Connecticut.
Alphabet to Pour $500 Million Into Sweeping Internal Reforms

3 weeks ago | news.bloomberglaw.com | Martina Barash

June 2, 2025, 4:10 PM UTC Google's Bay View campus in Mountain View, Calif. on May 1, 2024. Photographer: David Paul Morris/Bloomberg via Getty Images Alphabet Inc. has agreed to spend $500 million to improve its global regulatory compliance structure as a proposed resolution to a shareholder suit stemming from US antitrust allegations, according to a federal court filing.
Day-Trading Grandpa Denied High Court Look at Short-Swing Harm

3 weeks ago | news.bloombergtax.com | Martina Barash

A Microbot Medical Inc. investor won’t be able to take his defense against short-swing trading claims to the US Supreme Court, according to an order Monday. Octogenarian day trader Joseph Mona sought review of a US Court of Appeals for the Second Circuit decision that affirmed judgment in favor of Microbot and a disgorgement award of more than $480,000. Mona argued that the pre-clinical medical device company lacked standing to sue him because it didn’t suffer—or even allege—an actual injury.
Net Power Leaders Misrepresented Plant Schedule, Cost, Suit Says

4 weeks ago | news.bloomberglaw.com | Martina Barash

COURT: M.D.N.C.TRACK DOCKET: No. 1:25-cv-00431 (Bloomberg Law subscription)Net Power Inc. board members and top executives are responsible for the energy system developer’s failure to disclose a longer-than-anticipated timeline and increased costs for its pilot electricity generation plant, an investor says. One of the insiders sold company stock for $1.9 million in total proceeds while its price was artificially inflated due to the misrepresentations, Bryan Mott says on behalf of the company.
Inspire Medical Investor Drops Suit Against Board Over Program

4 weeks ago | news.bloombergtax.com | Martina Barash

An Inspire Medical Systems Inc. investor’s request to voluntarily dismiss his derivative suit over the sleep apnea device company’s prior authorization program is granted, a federal court ruled Thursday. Lawrence Hollin said in his request that he had decided to seek to inspect company books and records instead—a preliminary step to a possible new derivative suit on behalf of the company.
Inspire Medical Investor Drops Suit Against Board Over Program

4 weeks ago | news.bloomberglaw.com | Martina Barash

An Inspire Medical Systems Inc. investor’s request to voluntarily dismiss his derivative suit over the sleep apnea device company’s prior authorization program is granted, a federal court ruled Thursday. Lawrence Hollin said in his request that he had decided to seek to inspect company books and records instead—a preliminary step to a possible new derivative suit on behalf of the company.